Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iBio (IBIO) Revenue (2016 - 2025)

Historic Revenue for iBio (IBIO) over the last 17 years, with Q3 2025 value amounting to $100000.0.

  • iBio's Revenue changed N/A to $100000.0 in Q3 2025 from the same period last year, while for Dec 2025 it was $300000.0, marking a year-over-year decrease of 2000.0%. This contributed to the annual value of $400000.0 for FY2025, which is 7777.78% up from last year.
  • Per iBio's latest filing, its Revenue stood at $100000.0 for Q3 2025.
  • In the past 5 years, iBio's Revenue ranged from a high of $1.8 million in Q1 2022 and a low of $50000.0 during Q3 2023
  • Moreover, its 5-year median value for Revenue was $200000.0 (2024), whereas its average is $429444.4.
  • The largest annual percentage gain for iBio's Revenue in the last 5 years was 69687.5% (2021), contrasted with its biggest fall of 7951.22% (2021).
  • iBio's Revenue (Quarter) stood at $84000.0 in 2021, then skyrocketed by 2042.86% to $1.8 million in 2022, then crashed by 97.22% to $50000.0 in 2023, then soared by 300.0% to $200000.0 in 2024, then tumbled by 50.0% to $100000.0 in 2025.
  • Its Revenue was $100000.0 in Q3 2025, compared to $200000.0 in Q2 2025 and $200000.0 in Q4 2024.